94411 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO
#2COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO
#3METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#4Substituted imidazoles for preventing and/or treating cell or tissue necrosis
#5TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#6METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#7TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#8WDR5-MLL1 inhibitors and modulators
#9PESTICIDAL COMPOUNDS AND THEIR USES
#10METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#11TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#12Substituted thiazoles for preventing and/or treating cell or tissue necrosis
#13Substituted pyrazoles as inhibitors of fibroblast growth factor receptor
#14Substituted guanidines as fungicides
#15TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
#16Tetralin and indane derivatives and uses thereof
#17Methods of treating α adrenergic mediated conditions
#18Process for the preparation of acylguanidines and acylthioureas
#19Non-natural amino acids
#20NOVEL PROCESS FOR THE PREPARATION OF ACYLGUANIDINES AND ACYLTHIOUREAS
#21Methods of treating alpha adrenergic mediated conditions
#22Cyclic guanidine ionic liquid
#23Tetralin and indane derivatives and uses thereof
#24Selective subtype alpha 2 adrenergic agents and methods for use thereof
#251-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
#26Non-Natural Amino Acids and Neurotensin Analogues Thereof
#27Cyclic guanidine ionic liquid
#28Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
#29Methods of treating alpha adrenergic mediated conditions
#30Compounds effecting glucokinase
#31DIAMINE DERIVATIVE
#32Human adam-10 inhibitors
#33Tetralin and indane derivatives and uses thereof
#34Bisbenzamidines for the Treatment of Pneumonia
#35Melanocortin-4 receptor binding compounds and methods of use thereof
#36Non-natural amino acids and neurotensin analogues
#37Compounds effecting glucokinase
#381-(Imidazolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
#39Non-Natural Amino Acids
#40Heterocyclic compounds as P2X7 ion channel blockers
#41Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
#42Arylsulfonamidyl tetralin derivatives and uses thereof
#43Arylsulfonyl naphthalene derivatives and uses thereof
#44Creatine analog prodrugs, compositions and uses thereof
#45Ionic liquids containing guanidinium cations
#46CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
#47Process for the preparation of guanidinium salts
#48O-coordinated metal chelates and their use in optical recording media having high storage capacity
#49Tetralin and indane derivatives and uses thereof
#50Cycloalkyl inhibitors of potassium channel function
#51Human ADAM-10 inhibitors
#52Carboxylic acid amides
#53Compounds effecting glucokinase
#54Heterocyclic compounds as P2X7 ion channel blockers